These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 33220260

  • 1. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
    Jamalpour M, Bergquist E, Welsh M.
    Exp Cell Res; 2020 Dec 15; 397(2):112368. PubMed ID: 33220260
    [Abstract] [Full Text] [Related]

  • 2. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
    Fu JF, Yen TH, Huang YJ, Shih LY.
    Neoplasia; 2019 May 15; 21(5):469-481. PubMed ID: 30974389
    [Abstract] [Full Text] [Related]

  • 3. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
    Bindels EM, Havermans M, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, Rombouts E, Armstrong SA, Taskesen E, Haanstra JR, Beverloo HB, Döhner H, Hudson WA, Kersey JH, Delwel R, Kumar AR.
    Blood; 2012 Jun 14; 119(24):5838-49. PubMed ID: 22553314
    [Abstract] [Full Text] [Related]

  • 4. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
    Osaki H, Walf-Vorderwülbecke V, Mangolini M, Zhao L, Horton SJ, Morrone G, Schuringa JJ, de Boer J, Williams O.
    Leukemia; 2013 Jul 14; 27(7):1461-8. PubMed ID: 23403462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.
    Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC.
    Cancer Cell; 2008 Jun 14; 13(6):483-95. PubMed ID: 18538732
    [Abstract] [Full Text] [Related]

  • 7. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
    Chiarella E, Aloisio A, Scicchitano S, Todoerti K, Cosentino EG, Lico D, Neri A, Amodio N, Bond HM, Mesuraca M.
    Int J Mol Sci; 2021 Oct 06; 22(19):. PubMed ID: 34639154
    [Abstract] [Full Text] [Related]

  • 8. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG, Hess JL.
    Cancer Cell; 2008 Jun 06; 13(6):465-7. PubMed ID: 18538728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
    Hao C, Shao X, Song J, Peng M, Lao Y, Mack R, Zhang L, Wei W, Liu N, Wang T, Wu Y, Feng L, Yin L, Wang S, Sun X, Chen S, Zhang J, Li B.
    Biochem Biophys Res Commun; 2022 Mar 12; 596():36-42. PubMed ID: 35108652
    [Abstract] [Full Text] [Related]

  • 11. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
    Thiel AT, Blessington P, Zou T, Feather D, Wu X, Yan J, Zhang H, Liu Z, Ernst P, Koretzky GA, Hua X.
    Cancer Cell; 2010 Feb 17; 17(2):148-59. PubMed ID: 20159607
    [Abstract] [Full Text] [Related]

  • 12. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
    Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, Rabbitts TH, Kersey JH.
    Blood; 2003 Apr 15; 101(8):3229-35. PubMed ID: 12515728
    [Abstract] [Full Text] [Related]

  • 13. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
    Liu Q, Chen L, Atkinson JM, Claxton DF, Wang HG.
    Cell Death Dis; 2016 Sep 08; 7(9):e2361. PubMed ID: 27607576
    [Abstract] [Full Text] [Related]

  • 14. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.
    Tan J, Jones M, Koseki H, Nakayama M, Muntean AG, Maillard I, Hess JL.
    Cancer Cell; 2011 Nov 15; 20(5):563-75. PubMed ID: 22094252
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
    Nguyen AT, Taranova O, He J, Zhang Y.
    Blood; 2011 Jun 23; 117(25):6912-22. PubMed ID: 21521783
    [Abstract] [Full Text] [Related]

  • 17. Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia.
    Jamalpour M, Li X, Gustafsson K, Tyner JW, Welsh M.
    Tumour Biol; 2018 Apr 23; 40(4):1010428318771472. PubMed ID: 29792386
    [Abstract] [Full Text] [Related]

  • 18. Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Young K, Loberg MA, Eudy E, Schwartz LS, Mujica KD, Trowbridge JJ.
    Exp Hematol; 2020 Sep 23; 89():61-67.e3. PubMed ID: 32768438
    [Abstract] [Full Text] [Related]

  • 19. Learning from mouse models of MLL fusion gene-driven acute leukemia.
    Schwaller J.
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug 23; 1863(8):194550. PubMed ID: 32320749
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y, Ernst P.
    Cell Cycle; 2019 Jul 23; 18(14):1525-1531. PubMed ID: 31161857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.